Trial Profile
Does fluoxetine reverse the effects of early life stress on the CNS corticotropin-releasing factor system and improve psychological and neuroendocrine function?: a therapy outcome study in women with childhood abuse experiences
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 08 Apr 2009 Actual end date (November 2007) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2006 Status change